Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"MMWR. Morbidity and mortality weekly report"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Grannis%2C+Shaun%22&type=Person&filter%5B%5D=journalStr%3A%22MMWR.+Morbidity+and+mortality+weekly+report%22
/vufind/Search/Results?lookfor=%22Grannis%2C+Shaun%22&type=Person&filter%5B%5D=journalStr%3A%22MMWR.+Morbidity+and+mortality+weekly+report%22
Search /vufind/Search2/Results?lookfor=%22Grannis%2C+Shaun%22&type=Person&filter%5B%5D=journalStr%3A%22MMWR.+Morbidity+and+mortality+weekly+report%22
PubPharm (15)
1
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged ≥18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2024
von
Link-Gelles, R.
|
Rowley, E.
|
DeSilva, M.
| +31
Wird geladen...
2
Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years - VISION and IVY Networks, September 2023-January 2024
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2024
von
DeCuir, J.
|
Payne, A.
|
Self, W.
| +105
Wird geladen...
3
Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2023
von
Link-Gelles, R.
|
Ciesla, A.
|
Rowley, E.
| +31
Wird geladen...
4
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2023
von
Link-Gelles, R.
|
Weber, Z.
|
Reese, S.
| +32
Wird geladen...
5
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2023
von
Tenforde, M.
|
Weber, Z.
|
Natarajan, K.
| +38
RepublishedFrom: MMWR Morb Mortal Wkly Rep. 2023 Mar 17;72(11):292. - PMID 36927730
Wird geladen...
6
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults - VISION Network, Nine States, September-November 2022
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2022
von
Tenforde, M.
|
Weber, Z.
|
Natarajan, K.
| +38
ErratumIn: MMWR Morb Mortal Wkly Rep. 2023 Mar 17;72(11):292. - PMID 36927730
Wird geladen...
7
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2022
von
Britton, A.
|
Embi, P.
|
Levy, M.
| +41
Wird geladen...
8
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2022
von
Link-Gelles, R.
|
Levy, M.
|
Gaglani, M.
| +39
Wird geladen...
9
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2022
von
Natarajan, K.
|
Prasad, N.
|
Dascomb, K.
| +48
Wird geladen...
10
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022
enthalten in:
MMWR. Morbidity and mortality weekly report
| 2022
von
Klein, N.
|
Stockwell, M.
|
Demarco, M.
| +44
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: MMWR. Morbidity and mortality weekly report
Medienart
15
Aufsätze
15
E-Artikel
15
E-Ressourcen
Zeitschriftentitel
MMWR. Morbidity and mortality weekly report
Thema
14
Journal Article
13
COVID-19 Vaccines
6
mRNA Vaccines
5
Vaccines, Combined
4
RNA, Messenger
4
Vaccines, Synthetic
3
Influenza Vaccines
2
BNT162 Vaccine
2
N38TVC63NU
1
Antiviral Agents
1
Corrected and Republished Article
1
Technical Report
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2024
3
2023
7
2022
3
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
15
Englisch
Haven't found what you're looking for?
Wird geladen...